Related references
Note: Only part of the references are listed.Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia
Ehud Even-Or et al.
PEDIATRIC BLOOD & CANCER (2020)
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro
Shili Ge et al.
TRANSPLANTATION (2020)
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with autoimmune hemolytic anemia
Gwendolyn Ho et al.
BLOOD CELLS MOLECULES AND DISEASES (2020)
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jaeger et al.
BLOOD REVIEWS (2020)
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia
Vlatko Pejsa et al.
LEUKEMIA & LYMPHOMA (2020)
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects
Bruno Fattizzo et al.
FRONTIERS IN ONCOLOGY (2020)
Does clonal hematopoiesis explain unexplained anemia?
David P. Steensma
BLOOD (2020)
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures
Wilma Barcellini et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
The Changing Landscape of Autoimmune Hemolytic Anemia
Wilma Barcellini et al.
FRONTIERS IN IMMUNOLOGY (2020)
ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications
Peter Valent
PATHOBIOLOGY (2019)
Low-dose rituximab in autoimmune hemolytic anemia: 10 years after
Bruno Fattizzo et al.
BLOOD (2019)
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes
Jerome Hadjadj et al.
BLOOD (2019)
Warm Autoimmune Hemolytic Anemia
Robert A. Brodsky
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prognosis of autoimmune hemolytic anemia in critically ill patients
Antoine Lafarge et al.
ANNALS OF HEMATOLOGY (2019)
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
Wilma Barcellini et al.
JOURNAL OF BLOOD MEDICINE (2019)
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers
Wilma Barcellini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia
Bruno Fattizzo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
Matthijs D. Kruizinga et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Current and emerging treatment options for autoimmune hemolytic anemia
Wilma Barcellini et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept
Jennifer Hess et al.
TRANSFUSION (2018)
Venous thromboembolic events during warm autoimmune hemolytic anemia
Sylvain Audia et al.
PLOS ONE (2018)
Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation
Catharina Schuetz et al.
BLOOD ADVANCES (2018)
A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)
Marc Michel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS CARE & RESEARCH (2017)
The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity
Wilma Barcellini
EXPERT REVIEW OF HEMATOLOGY (2017)
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
M. Montillo et al.
BLOOD CANCER JOURNAL (2017)
Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)
Marcelo Pitombeira de Lacerda et al.
ANNALS OF HEMATOLOGY (2017)
Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/ dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes
Wilma Barcellini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia
K. A. Rogers et al.
LEUKEMIA (2016)
Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia
Ekarat Rattarittamrong et al.
HEMATOLOGY (2016)
Danazol Treatment for Telomere Diseases
Danielle M. Townsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes
Anna Zaninoni et al.
TRANSFUSION (2016)
Warm antibody autoimmune hemolytic anemia
Theodosia A. Kalfa
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias
Bruno Fattizzo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)
Anne Quinquenel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies
Quitterie Reynaud et al.
AUTOIMMUNITY REVIEWS (2015)
Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of 533 Adult Patients Who Underwent Transplantation at King's College Hospital
Meng Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
W. Barcellini et al.
DISEASE MARKERS (2015)
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Wilma Barcellini
TRANSFUSION MEDICINE AND HEMOTHERAPY (2015)
Autoimmune cytopenias in chronic lymphocytic leukemia
Carlo Visco et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients
Mathilde Roumier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini et al.
BLOOD (2014)
Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new
Kam Newman et al.
AUTOIMMUNITY REVIEWS (2013)
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
Henrik Birgens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Ofatumumab in Rituximab-Refractory Autoimmune Hemolytic Anemia Associated With Chronic Lymphocytic Leukemia: A Case Report and Review of Literature
Kamyar Nader et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Increased prevalence of autoimmune phenomena in myelofibrosis: Relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns
Wilma Barcellini et al.
LEUKEMIA RESEARCH (2013)
Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor
Melissa A. Acquazzino et al.
PEDIATRIC TRANSPLANTATION (2013)
Outcomes and complications after splenectomy for hematologic disorders
Nirav Y. Patel et al.
AMERICAN JOURNAL OF SURGERY (2012)
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini et al.
BLOOD (2012)
Immune hemolytic anemia caused by drugs
George Garratty
EXPERT OPINION ON DRUG SAFETY (2012)
Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia
J. Rossignol et al.
LEUKEMIA (2011)
The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis
Maria Allhorn et al.
BLOOD (2010)
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone
Deborah A. Bowen et al.
LEUKEMIA & LYMPHOMA (2010)
Risk for Hospital Contact With Infection in Patients With Splenectomy A Population-Based Cohort Study
Reimar W. Thomsen et al.
ANNALS OF INTERNAL MEDICINE (2009)
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases
Marc Michel et al.
BLOOD (2009)
A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia
Matthew Kaufman et al.
LEUKEMIA & LYMPHOMA (2009)
Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia
L. Laurenti et al.
LEUKEMIA (2007)
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)
C. Karlsson et al.
LEUKEMIA (2007)
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
Giovanni D'Arena et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
The changing spectrum of drug-induced immune hemolytic anemia
PA Arndt et al.
SEMINARS IN HEMATOLOGY (2005)
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia
N Gupta et al.
LEUKEMIA (2002)
High-dose cyclophosphamide for refractory autoimmune hemolytic anemia
VM Moyo et al.
BLOOD (2002)
Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura
J Howard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
